Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs35992251 | chr2:24288897 | G/A | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs35994878 | chr16:89949033 | T/C | 0.00016 | 174 | 25.87 | 22.63 | 36.37 | KM Plot |
PCPG | rs35997713 | chr5:179415609 | CATTT/C | 0.000243 | 176 | 24.1 | 34.73 | 14.83 | KM Plot |
PCPG | rs36020663 | chr14:74320838 | T/C | 1.06E-5 | 177 | 25.47 | 28.38 | 10.3 | KM Plot |
PCPG | rs36043566 | chr2:242557028 | G/C | 4.1E-11 | 178 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs36056191 | chr3:161092196 | GA/G | 0.000268 | 172 | 25.87 | 19.85 | 3.17 | KM Plot |
PCPG | rs36064904 | chr16:1720875 | C/T | 0 | 178 | 25.53 | 18.75 | 2.93 | KM Plot |
PCPG | rs36065173 | chr17:50272817 | T/TA | 8.03E-5 | 174 | 25.77 | 28.47 | 14.47 | KM Plot |
PCPG | rs36066123 | chr3:150893913 | G/A | 6.3E-11 | 171 | 24.85 | 33.13 | 10.3 | KM Plot |
PCPG | rs36086089 | chr18:44143153 | C/T | 1.22E-7 | 176 | 25.08 | 26.57 | 19.87 | KM Plot |
PCPG | rs36088050 | chr2:242520091 | A/C | 4.22E-5 | 177 | 25.87 | 25.67 | 20.2 | KM Plot |
PCPG | rs36090694 | chr3:53010742 | T/C | 6.05E-6 | 178 | 25.28 | 26.05 | 11.78 | KM Plot |
PCPG | rs36092914 | chr15:43100623 | C/A | 2.29E-14 | 177 | 25.53 | 24.7 | 3.17 | KM Plot |
PCPG | rs36098732 | chr14:74494081 | C/T | 5.79E-7 | 173 | 25.17 | 28.38 | 7.4 | KM Plot |
PCPG | rs36114385 | chr16:90038369 | A/G | 1.26E-8 | 171 | 25.77 | 20.2 | 6.62 | KM Plot |